A Phase 2 Study of 9-ING-41Combined With Chemotherapy in Adolescents and Adults With Advanced Sarcomas

NCT04906876 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped IND withdrawn

Conditions

Sarcoma
Soft Tissue Sarcoma
Metastatic Sarcoma
Undifferentiated Pleomorphic Sarcoma
Myxofibrosarcoma
Leiomyosarcoma
Liposarcoma
Angiosarcoma
Synovial Sarcoma
Rhabdomyosarcoma
Spindle Cell Sarcoma
High Grade Sarcoma
Bone Sarcoma

Interventions

DRUG: Gemcitabine
DRUG: Docetaxel
DRUG: 9-ING-41

Sponsor

Brown University

Collaborators

[object Object]